Biospecimen Research Network (OBBR)

Information

  • Research Project
  • 8241853
  • ApplicationId
    8241853
  • Core Project Number
    261200800001E-38-0-73
  • Full Project Number
    261200800001E-38-0-73
  • Serial Number
    0
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/26/2008 - 16 years ago
  • Project End Date
    9/25/2018 - 6 years ago
  • Program Officer Name
  • Budget Start Date
    -
  • Budget End Date
    -
  • Fiscal Year
    2011
  • Support Year
  • Suffix
  • Award Notice Date
    -

Biospecimen Research Network (OBBR)

This contract funding supports the Biospecimen Research Network, managed by the National Cancer Institute (NCI) Office of Biorepositories and Biospecimen Research."In early 2006, the NCI Office of Biorepositories and Biospecimen Research (OBBR) initiated the Biospecimen Research Network (BRN) to systematically address the impact of specific variables in individual specimen types on molecular data from given analysis platforms. The goal of the BRN is to address these issues by sponsoring, conducting, and collaborating on studies to assess the effects of human specimen pre-analytical variables on the outcome of genomic and proteomic studies conducted for clinical diagnosis and cancer research purposes. By communicating the results of such research to the scientific community, the BRN aims to significantly improve the quality of NCI-funded biospecimen-based research. The results of BRN research will support NCI discovery efforts and contribute to the development of evidence-based best practices for the collection, processing, storage, and analysis of biospecimens, building on the ""NCI Best Practices for Biospecimen Resources."" Based on this vision, the BRN has been designed to address the following challenges: * Bridging the gap between existing clinical practice for biospecimens and emerging technologies for personalized diagnostics and therapies * Defining the most significant variables for prospective collection of tissues, blood, and bodily fluids * Developing evidence-based biospecimen quality indicators for specific analytical platforms The activities of the BRN program to date include the following: * A public outreach effort to define issues around human specimen research and identify the most pressing needs for human analyte standardization. Activities include an annual meeting, the BRN Symposium. * Provision of consultative services on biospecimen issues for programs within the NCI and NIH * A series of research projects underway at the BRN laboratory located at the Advanced Technology Center in Gaithersburg with intramural and extramural collaborators * Development of a searchable Web site of the existing biospecimen literature, the Biospecimen Research Database "

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    N01
  • Administering IC
    CA
  • Application Type
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    1336293
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    396
  • Ed Inst. Type
  • Funding ICs
    NCI:1336293\
  • Funding Mechanism
    Contracts, Extramural
  • Study Section
  • Study Section Name
  • Organization Name
    LEIDOS BIOMEDICAL RESEARCH, INC.
  • Organization Department
  • Organization DUNS
    159990456
  • Organization City
    FREDERICK
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    217029242
  • Organization District
    UNITED STATES